668 related articles for article (PubMed ID: 23006238)
21. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
22. The risks and benefits of clozapine versus chlorpromazine.
Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
[TBL] [Abstract][Full Text] [Related]
23. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
24. Clozapine-induced myocarditis.
Caetano D; Gandhi C
Aust N Z J Psychiatry; 2008 May; 42(5):434-5. PubMed ID: 18499933
[No Abstract] [Full Text] [Related]
25. Review and management of clozapine side effects.
Miller DD
J Clin Psychiatry; 2000; 61 Suppl 8():14-7; discussion 18-9. PubMed ID: 10811238
[TBL] [Abstract][Full Text] [Related]
26. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].
van Gool AR; van der Velden MT; Oosten AW; van Meerten E; Verhoeven WM; Loonen AJ
Tijdschr Psychiatr; 2008; 50(10):673-8. PubMed ID: 18951346
[TBL] [Abstract][Full Text] [Related]
28. Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
Citrome L; McEvoy JP; Saklad SR
Clin Schizophr Relat Psychoses; 2016; 10(3):163-177. PubMed ID: 27732102
[TBL] [Abstract][Full Text] [Related]
29. Optimizing clozapine treatment.
Naber D
J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
[TBL] [Abstract][Full Text] [Related]
30. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
31. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
Lang UE; Willbring M; von Golitschek R; Schmeisser A; Matschke K; Malte Tugtekin S
J Psychopharmacol; 2008 Jul; 22(5):576-80. PubMed ID: 18308817
[TBL] [Abstract][Full Text] [Related]
32. Observations from 8 cases of clozapine rechallenge after development of myocarditis.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; McNeil JJ
J Clin Psychiatry; 2012 Feb; 73(2):252-4. PubMed ID: 22401481
[No Abstract] [Full Text] [Related]
33. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
34. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
[TBL] [Abstract][Full Text] [Related]
35. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
Herceg M; Muzinić L; Jukić V
Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
[TBL] [Abstract][Full Text] [Related]
36. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
37. Myocarditis due to clozapine.
Prescrire Int; 2001 Jun; 10(53):83. PubMed ID: 11718172
[TBL] [Abstract][Full Text] [Related]
38. [Clozapine--the neglected potential].
Munitz H
Harefuah; 2012 May; 151(5):298-300, 318, 317. PubMed ID: 22844735
[TBL] [Abstract][Full Text] [Related]
39. Clozapine, agranulocytosis, and benign ethnic neutropenia.
Rajagopal S
Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
[No Abstract] [Full Text] [Related]
40. A review of clozapine safety.
Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
